BGLC vs J · rev $9.5M vs P/E 36, $14.40B cap
BioNexus Gene Lab Corp Common stock (BGLC) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
J does not have a complete income-statement cache yet.
BGLC currently screens at market cap $6.1M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the BGLC and J stock pages for the full models.
Not investment advice.